Stromal Therapeutics

Switzerland
Breíl, Grisons, Switzerland, 4057

Company profile

Stromal Therapeutics company profile

Stromal Therapeutics is the first biotechnological spin-off from the Kantonsspital St.Gallen. Stromal Therapeutics Building on the group’s unique domain expertise, the company has deployed state-of-the-art single-cell sequencing of human tissues to molecularly unravel the interplay of stromal tissue cytokines with the immune system

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2018-11-01, Month

Headquarters

Postal code
4057
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$536,906
Last funding
Seed / $536,906 / 2022-01-28
Last equity funding
Seed / $536,906
Investors
1
Lead investors
1
Founders
1

Founders and investors

Founders

Burkhard Ludewig

Lead investors

BaseLaunch

Investors

BaseLaunch